Effects of Visual Biofeedback Therapy in Parkinson's Patients
Launched by ZIAUDDIN UNIVERSITY · Apr 12, 2022
Trial Information
Current as of July 01, 2025
Unknown status
Keywords
ClinConnect Summary
A total number of 36 patients will be recruited in the study. After the voluntary consent, all the patients will be randomly divided into Group A and B through the envelope method of simple random sampling. In addition, a total of 36 sealed envelopes, comprised of 18 envelopes for each group will be presented to the patients. Each patient will be asked to select one envelope of their choice. Upon selection of the envelope, patients will be allocated to the respective group. Thus, each group will comprise 18 patients respectively. Afterward, pre-assessment will be performed for each patient ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Parkinson's disease of age between 60-79 years.
- • Diagnosed PD stage III.
- Exclusion Criteria:
- • Other neurological problems (Multiple sclerosis, amyotrophic lateral sclerosis and myasthenia gravis).
- • Migraine.
- • Auditory or visual deficits.
- • Orthostatic hypotension.
About Ziauddin University
Ziauddin University is a prestigious academic institution located in Karachi, Pakistan, dedicated to advancing medical education, research, and healthcare. As a clinical trial sponsor, Ziauddin University actively engages in innovative research initiatives aimed at improving patient outcomes and contributing to the global body of medical knowledge. With a commitment to ethical standards and scientific rigor, the university collaborates with healthcare professionals, researchers, and regulatory bodies to conduct clinical trials that address critical health challenges. Through its multidisciplinary approach, Ziauddin University strives to foster a culture of research excellence and enhance the quality of healthcare services in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Karachi, Sindh, Pakistan
Patients applied
Trial Officials
Fouzia Hussain, MPhil
Principal Investigator
Ziauddin University Karachi, Sindh, Pakistan
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials